BioCartilage® ECM and the Rationale to Treat All Osteochondral Lesions of the Talus

Anish R. Kadakia, MD, (Chicago, IL) describes why he chooses BioCartilage® extracellular matrix when treating osteochondral lesions of the talus. Dr. Kadakia also discusses his prospective clinical study using BioCartilage extracellular matrix and his 2-year postoperative results.

Kategorie:
Präsentator:
Veröffentlichungsdatum:
Dauer:
Referenznummer:
Version: